{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:56:01Z","timestamp":1795042561155,"version":"4.10.2"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.antiviral.2019.104558","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T11:10:28Z","timestamp":1562843428000},"page":"104558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors"],"prefix":"10.1016","volume":"169","author":[{"given":"Yu-Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Cubitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell V.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab K.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens H.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104558_bib1","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1128\/JVI.77.15.8181-8186.2003","article-title":"Host factors in positive-strand RNA virus genome replication","volume":"77","author":"Ahlquist","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2174\/1570159X14666161208151525","article-title":"From leflunomide to teriflunomide: drug development and immunosuppressive oral drugs in the treatment of multiple sclerosis","volume":"15","author":"Aly","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.antiviral.2019.104558_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.104558_bib4","series-title":"ML311: A Small Molecule that Potently and Selectively Disrupts the Protein-Protein Interaction of Mcl-1 and Bim: A Probe for Studying Lymphoid Tumorigenesis, Probe Reports from the NIH Molecular Libraries Program, Bethesda (MD)","author":"Bannister","year":"2010"},{"key":"10.1016\/j.antiviral.2019.104558_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2014.06.005","article-title":"Teriflunomide (Aubagio(R)) for the treatment of multiple sclerosis","volume":"262","author":"Bar-Or","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.antiviral.2019.104558_bib6","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1067\/mob.2002.126297","article-title":"Lymphocytic choriomeningitis virus: emerging fetal teratogen","volume":"187","author":"Barton","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.antiviral.2019.104558_bib7","first-page":"6","article-title":"[Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates]","volume":"10","author":"Battegay","year":"1993","journal-title":"ALTEX"},{"key":"10.1016\/j.antiviral.2019.104558_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2005.10.008","article-title":"Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses","volume":"69","author":"Bolken","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib9","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2019.104558_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00151-11","article-title":"Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins","volume":"2","author":"Bortz","year":"2011","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.104558_bib11","series-title":"Field's Virology","first-page":"1791","article-title":"Arenaviridae: the viruses and their replication","author":"Buchmeier","year":"2007"},{"key":"10.1016\/j.antiviral.2019.104558_bib12","series-title":"Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays","author":"Cai","year":"2018"},{"key":"10.1016\/j.antiviral.2019.104558_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virol.2008.09.008","article-title":"A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding","volume":"382","author":"Capul","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104558_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2011.02.012","article-title":"Evaluation of Lassa antiviral compound ST-193 in a Guinea pig model","volume":"90","author":"Cashman","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib15","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/AAC.00282-16","article-title":"Discovery of a broad-spectrum antiviral compound that inhibits pyrimidine biosynthesis and establishes a type 1 interferon-independent antiviral state","volume":"60","author":"Chung","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104558_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0065-3527(02)58004-0","article-title":"Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy","volume":"58","author":"Damonte","year":"2002","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib17","doi-asserted-by":"crossref","first-page":"35324","DOI":"10.1074\/jbc.M112.392142","article-title":"Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection","volume":"287","author":"Denisova","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104558_bib18","first-page":"51","article-title":"Viruses as quasispecies: biological implications","volume":"299","author":"Domingo","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.104558_bib19","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.0900088106","article-title":"Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest","volume":"106","author":"Emonet","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104558_bib20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JVI.02102-10","article-title":"Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease","volume":"85","author":"Emonet","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of Argentine hemorrhagic fever","volume":"78","author":"Enria","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib22","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1128\/JVI.00008-06","article-title":"Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins","volume":"80","author":"Eschli","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib23","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa053240","article-title":"Transmission of lymphocytic choriomeningitis virus by organ transplantation","volume":"354","author":"Fischer","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104558_bib24","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/ijc.23788","article-title":"Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells","volume":"123","author":"Floryk","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2019.104558_bib25","first-page":"865","article-title":"Emerging infectious diseases and risk to the traveler","volume":"83","author":"Freedman","year":"1999","journal-title":"Med. Clin. N. Am."},{"key":"10.1016\/j.antiviral.2019.104558_bib26","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2019.104558_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nchembio.2287","article-title":"The pharmacological regulation of cellular mitophagy","volume":"13","author":"Georgakopoulos","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2019.104558_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0042-6822(89)90375-9","article-title":"Vesicular stomatitis virus and its defective interfering particles exhibit in vitro transcriptional and replicative competition for purified L-NS polymerase molecules","volume":"170","author":"Giachetti","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104558_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002614","article-title":"Favipiravir (T-705) inhibits Junin virus infection and reduces mortality in a Guinea pig model of Argentine hemorrhagic fever","volume":"7","author":"Gowen","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104558_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10408360490497456","article-title":"Lassa virus","volume":"41","author":"Gunther","year":"2004","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.antiviral.2019.104558_bib31","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1086\/322620","article-title":"Viral hemorrhagic fever hazards for travelers in Africa","volume":"33","author":"Isaacson","year":"2001","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.antiviral.2019.104558_bib32","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/sj.onc.1208739","article-title":"Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF\/Endo G pathway","volume":"24","author":"Ishitsuka","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2019.104558_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02256-17","article-title":"A highly conserved leucine in mammarenavirus matrix Z protein is required for Z interaction with the virus L polymerase and Z stability in cells harboring an active viral ribonucleoprotein","volume":"92","author":"Iwasaki","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006892","article-title":"Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+\/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses","volume":"14","author":"Iwasaki","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104558_bib35","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/JVI.02110-13","article-title":"Sodium hydrogen exchangers contribute to arenavirus cell entry","volume":"88","author":"Iwasaki","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.tim.2015.04.006","article-title":"Emerging intracellular receptors for hemorrhagic fever viruses","volume":"23","author":"Jae","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2019.104558_bib37","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.1252480","article-title":"Virus entry. Lassa virus entry requires a trigger-induced receptor switch","volume":"344","author":"Jae","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104558_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/2049-632X.12171","article-title":"The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens","volume":"71","author":"Jahrling","year":"2014","journal-title":"Pathog Dis"},{"key":"10.1016\/j.antiviral.2019.104558_bib39","first-page":"486","article-title":"Lymphocytic choriomeningitis virus. A neglected pathogen of man","volume":"116","author":"Jahrling","year":"1992","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.antiviral.2019.104558_bib40","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1073\/pnas.1810137115","article-title":"The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis","volume":"115","author":"Janes","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"116","key":"10.1016\/j.antiviral.2019.104558_bib41","doi-asserted-by":"crossref","DOI":"10.3791\/52317","article-title":"Safety precautions and operating procedures in an (A)BSL-4 laboratory: 1. Biosafety level 4 suit laboratory suite entry and exit procedures","author":"Janosko","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.antiviral.2019.104558_bib42","doi-asserted-by":"crossref","first-page":"41660","DOI":"10.1038\/srep41660","article-title":"Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment","volume":"7","author":"Kai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104558_bib43","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1165\/rcmb.2013-0003OC","article-title":"Reactive oxygen species induce antiviral innate immune response through IFN-lambda regulation in human nasal epithelial cells","volume":"49","author":"Kim","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.104558_bib44","first-page":"111","article-title":"Receptor structure, binding, and cell entry of arenaviruses","volume":"262","author":"Kunz","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.104558_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11120-016-0217-2","article-title":"The antimycin A-sensitive pathway of cyclic electron flow: from 1963 to 2015","volume":"129","author":"Labs","year":"2016","journal-title":"Photosynth. Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib46","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1128\/JVI.00941-08","article-title":"Identification of a broad-spectrum arenavirus entry inhibitor","volume":"82","author":"Larson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.virol.2010.11.022","article-title":"Novel approaches in anti-arenaviral drug development","volume":"411","author":"Lee","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104558_bib48","doi-asserted-by":"crossref","first-page":"18734","DOI":"10.1074\/jbc.M802089200","article-title":"Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104558_bib49","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1128\/JVI.76.12.6393-6397.2002","article-title":"Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles","volume":"76","author":"Lee","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib50","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4161\/cbt.8.16.8964","article-title":"Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists","volume":"8","author":"Lestini","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.antiviral.2019.104558_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003678","article-title":"Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity","volume":"9","author":"Lucas-Hourani","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104558_bib52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.antiviral.2018.08.012","article-title":"Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses","volume":"158","author":"Luthra","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060579","article-title":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PLoS One"},{"issue":"116","key":"10.1016\/j.antiviral.2019.104558_bib54","doi-asserted-by":"crossref","DOI":"10.3791\/53600","article-title":"Safety precautions and operating procedures in an (A)BSL-4 laboratory: 2. General practices","author":"Mazur","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.antiviral.2019.104558_bib55","series-title":"Lassa Fever","author":"McCormick","year":"2002"},{"key":"10.1016\/j.antiviral.2019.104558_bib56","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.01219-10","article-title":"T-705 (favipiravir) inhibition of arenavirus replication in cell culture","volume":"55","author":"Mendenhall","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104558_bib57","doi-asserted-by":"crossref","first-page":"e1342","DOI":"10.1371\/journal.pntd.0001342","article-title":"Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever","volume":"5","author":"Mendenhall","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104558_bib58","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.bmc.2010.04.017","article-title":"Structural determinants for the inhibitory ligands of orotidine-5'-monophosphate decarboxylase","volume":"18","author":"Meza-Avina","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104558_bib59","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/acsinfecdis.7b00236","article-title":"Mining a krohnke pyridine library for anti-arenavirus activity","volume":"4","author":"Miranda","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104558_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.antiviral.2015.05.003","article-title":"Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses","volume":"120","author":"Mohr","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib61","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1128\/JVI.00614-11","article-title":"Ribavirin can be mutagenic for arenaviruses","volume":"85","author":"Moreno","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.intimp.2009.09.026","article-title":"Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection","volume":"10","author":"Nakanishi","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2019.104558_bib63","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12885-015-1582-5","article-title":"Obatoclax is a direct and potent antagonist of membrane-restricted Mcl-1 and is synthetic lethal with treatment that induces Bim","volume":"15","author":"Nguyen","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.antiviral.2019.104558_bib64","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis","volume":"104","author":"Nguyen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104558_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.242","article-title":"Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis","volume":"7","author":"Ohmer","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.antiviral.2019.104558_bib66","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1128\/JVI.00257-16","article-title":"Lassa virus cell entry via dystroglycan involves an unusual pathway of macropinocytosis","volume":"90","author":"Oppliger","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib67","doi-asserted-by":"crossref","first-page":"28953","DOI":"10.1038\/srep28953","article-title":"Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas","volume":"6","author":"Osaki","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104558_bib68","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa073785","article-title":"A new arenavirus in a cluster of fatal transplant-associated diseases","volume":"358","author":"Palacios","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104558_bib69","doi-asserted-by":"crossref","first-page":"19036","DOI":"10.1073\/pnas.1113643108","article-title":"RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses","volume":"108","author":"Panda","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104558_bib70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virusres.2004.11.006","article-title":"Metabolism and antiviral activity of ribavirin","volume":"107","author":"Parker","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib71","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1073\/pnas.2133782100","article-title":"The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies","volume":"100","author":"Perez","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104558_bib72","first-page":"65","article-title":"Human infection with arenaviruses in the Americas","volume":"262","author":"Peters","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2019.104558_bib73","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1056\/NEJMp068021","article-title":"Lymphocytic choriomeningitis virus--an old enemy up to new tricks","volume":"354","author":"Peters","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104558_bib74","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.1332709100","article-title":"Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein","volume":"100","author":"Pinschewer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104558_bib75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.104558_bib76","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.1128\/JVI.00997-15","article-title":"Novel arenavirus entry inhibitors discovered by using a minigenome rescue system for high-throughput drug screening","volume":"89","author":"Rathbun","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082318","article-title":"Discovery of potent broad spectrum antivirals derived from marine actinobacteria","volume":"8","author":"Raveh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104558_bib78","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4614-7651-1_9","article-title":"Entry of rhabdoviruses into animal cells","volume":"790","author":"Regan","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2019.104558_bib79","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02229-10","article-title":"Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses","volume":"85","author":"Rodrigo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib80","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1128\/JVI.00560-08","article-title":"Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses","volume":"82","author":"Rojek","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib81","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1038\/srep14775","article-title":"The broad-spectrum antiviral favipiravir protects Guinea pigs from lethal Lassa virus infection post-disease onset","volume":"5","author":"Safronetz","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104558_bib82","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/mt.2010.188","article-title":"VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia","volume":"18","author":"Samuel","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2019.104558_bib83","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0092-8674(00)81275-1","article-title":"Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid","volume":"85","author":"Sintchak","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.104558_bib84","doi-asserted-by":"crossref","first-page":"60060","DOI":"10.18632\/oncotarget.11085","article-title":"BH3 mimetic Obatoclax (GX15-070) mediates mitochondrial stress predominantly via MCL-1 inhibition and induces autophagy-dependent necroptosis in human oral cancer cells","volume":"8","author":"Sulkshane","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.antiviral.2019.104558_bib85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","article-title":"Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia","volume":"167","author":"Sykes","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.104558_bib86","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1128\/JVI.06604-11","article-title":"The PI3K\/Akt pathway contributes to arenavirus budding","volume":"86","author":"Urata","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib87","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02227-16","article-title":"Obatoclax inhibits alphavirus membrane fusion by neutralizing the acidic environment of endocytic compartments","volume":"61","author":"Varghese","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104558_bib88","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.antiviral.2013.05.012","article-title":"Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid","volume":"99","author":"Vazquez-Calvo","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib89","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1128\/JVI.02510-10","article-title":"Inhibition of dengue virus through suppression of host pyrimidine biosynthesis","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104558_bib90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2016.10.007","article-title":"Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems","volume":"136","author":"Welch","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104558_bib91","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/v5020528","article-title":"Arenavirus budding: a common pathway with mechanistic differences","volume":"5","author":"Wolff","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104558_bib92","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.2147\/OTT.S146228","article-title":"MCL-1 inhibition in cancer treatment","volume":"11","author":"Xiang","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.antiviral.2019.104558_bib93","doi-asserted-by":"crossref","first-page":"10932","DOI":"10.1128\/JVI.01140-08","article-title":"pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors","volume":"82","author":"York","year":"2008","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421930244X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421930244X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:34Z","timestamp":1759062634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421930244X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":93,"alternative-id":["S016635421930244X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104558","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104558"}}